Advertisement
Canada markets close in 3 hours 20 minutes
  • S&P/TSX

    21,765.86
    +57.42 (+0.26%)
     
  • S&P 500

    4,966.73
    -44.39 (-0.89%)
     
  • DOW

    37,839.25
    +63.87 (+0.17%)
     
  • CAD/USD

    0.7271
    +0.0007 (+0.10%)
     
  • CRUDE OIL

    82.94
    +0.21 (+0.25%)
     
  • Bitcoin CAD

    87,716.66
    +11.38 (+0.01%)
     
  • CMC Crypto 200

    1,369.48
    +56.86 (+4.33%)
     
  • GOLD FUTURES

    2,406.80
    +8.80 (+0.37%)
     
  • RUSSELL 2000

    1,938.75
    -4.21 (-0.22%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,314.75
    -286.75 (-1.84%)
     
  • VOLATILITY

    18.98
    +0.98 (+5.44%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

On top of those pluses, these three companies all have a history of offering above-average dividends, making them solid long-term value bargains. Takeda is a Japanese biopharmaceutical company that focuses on gastroenterology, oncology, neuroscience, and rare diseases. The company's stock is up more than 9% this year, currently trading at just shy of $15.